SCHEMBL6166822

SCHEMBL6166822

O=C1CCc2c1c(-c1ccccc1F)nn2CCO

nearest known ligand 0.44

Predicted protein targets (top 14)

geneUniProtsupporting neighboursconfidence
HTT P42858 1/20 0.44
KDM4E B2RXH2 2/20 0.40
BRD4 O60885 2/20 0.34
CREBBP Q92793 2/20 0.34
ALDH1A1 P00352 3/20 0.33
KMT2A Q03164 2/20 0.33
GAA P10253 1/20 0.33
HRH3 Q9Y5N1 1/20 0.32
MEN1 O00255 1/20 0.32
PDCD1 Q15116 2/20 0.32
CD274 Q9NZQ7 2/20 0.32
MAPT P10636 1/20 0.32
TOP2A P11388 1/20 0.32
TOP2B Q02880 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6165983 0.84 ATM (0.44) KDM4EBRD4CREBBPALDH1A1KMT2A
SCHEMBL6164169 0.82 HTT (0.48) HTTKDM4ECREBBPALDH1A1KMT2A
SCHEMBL6167339 0.76 HTT (0.45) HTTKDM4EALDH1A1KMT2AGAA
SCHEMBL6166050 0.75 HTT (0.47) HTTALDH1A1
SCHEMBL6161914 0.75 HTT (0.44) HTTKDM4EALDH1A1KMT2AGAA
SCHEMBL6164980 0.75 HTT (0.44) HTT
SCHEMBL6162358 0.74 HTT (0.46) HTTKDM4ECREBBPALDH1A1KMT2A
SCHEMBL6164630 0.74 HTT (0.41) HTTKDM4EALDH1A1KMT2AGAA
SCHEMBL6164117 0.72 HTT (0.46) HTTKMT2AHRH3MEN1MAPT
SCHEMBL6164255 0.72 HTT (0.46) HTTKDM4EALDH1A1KMT2AMEN1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1177185-B1 4, 5, 6, 7-TETRAHYDROINDAZOLE DERIVATIVES AS ANTITUMOR AGENTS PHARMACIA ITALIA SPA (IT) 2005-04-20 EP disclosed
US-6716856-B1 CELL PROLIFERATIVE DISORDERS OR ALZHEIMER'S DISEASE; REDUCED TOXICITY; CDK/CYCLIN KINASE INHIBITORY ACTIVITY PHARMACIA & TUBJOHN SPA (IT) 2004-04-06 US disclosed